Emcure Pharmaceuticals IPO booked over 13 times so far on Day 3. Check GMP and other details

Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.